melanomaPRAMEhigh-risk malignanciesCenter for Cancer and Immunology Research at Children’s National Hospital
…at TAA-T products targeting preferentially expressed antigen in melanoma (PRAME) can be transduced with a TGFbRII dominant negative rece…
1articles mentioning diseases
1disease mentions
1distinct diseases extracted
0%of mentions human-reviewed
Active filtersEntity: high-risk malignancies ×
high-risk malignancies
This disease is selected. Its supporting articles are shown below.